Tag: Stem Cells
Improvements Seen in Post-Allo-HCT Outcomes for Seniors With Leukemia
Reduction in relapse incidence observed over time, as well as improvement in leukemia-free survival, overall survival
Outcomes Similar for Therapy-Related, De Novo MDS After Haplo-HSCT
Three-year overall and disease-free survival, three-year cumulative incidence of relapse similar between the groups
Risk for Vitiligo Increased for Transplant Recipients
Increased risk seen for those receiving allogeneic grafts and autologous grafts, as well as those with and without comorbid GVHD
Allogeneic HCT After Primary Induction Failure Beneficial in Leukemia
Overall survival rates were 29.8 and 21.6 percent five and 10 years after hematopoietic stem cell transplant
Peripheral Blood Haplo-SCT Feasible for Leukemia Patients 70 Years and Older
Haploidentical stem cell transplantation using nonmyeloablative conditioning regimen effective in highly selected patients
Stem Cell Transplant Effective for Knee Osteoarthritis
Most significant pain relief see with adipose‐derived and umbilical cord‐derived stem cells at different postoperative months
Gut Microbiota Influences Survival After Pediatric Stem Cell Transplant
Diversity and composition of gut microbiota before transplantation associated with survival
Younger Patients With Multiple Myeloma Can Achieve Durable Survival
Depth of response following autologous stem cell transplant remains a key predictor of survival
European Man May Be Sixth Person to Be ‘Cured’ of HIV
All received stem cell transplants to treat cancer; however, sixth patient did not receive the transplant from a donor with a rare genetic abnormality that is resistant to HIV
Spleen Volume Linked to Outcome After HSCT for Leukemia Patients
Higher spleen volume tied to inferior overall survival and increased incidence of nonrelapse mortality for patients with AML undergoing hematopoietic stem cell transplant
